|
[1]
|
Weidner, N. and Santa C.D. (1987) Phosphaturic Mesenchymal Tumors. A Polymorphous Group Causing Osteomalacia or Rickets. Cancer, 59, 1442-1454. [Google Scholar] [CrossRef]
|
|
[2]
|
Wu, H.W., Bui, M.M. et al. (2019) Phosphaturic Mesenchymal Tumor with an Admixture of Epithelial and Mesenchymal Elements in the Jaws: Clinicopathological and Immunohistochemical Analysis of 22 Cases with Literature Review. Modern Pa-thology, 32, 189-204. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Folpe, A.L. (2019) Phosphaturic Mesen-chymal Tumors: A Review and Update. Seminars in Diagnostic Pathology, 36, 260-268. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Tenenhouse, H.S. (2007) Phosphate Transport: Molecular Basis, Regulation and Pathophysiology. The Journal of Steroid Biochemistry and Molecular Biology, 103, 572-577. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Shimada, T., Mizutani, S., Muto, T., Yoneya, T., et al. (2001) Cloning and Characterization of FGF23 as a Causative Factor of Tumor-Induced Osteomalacia. Proceedings of the Na-tional Academy of Sciences, 98, 6500-6505. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Dutta, D., Pandey, R.K., Gogoi, R., et al. (2018) Occult Phosphaturic Mesenchymal Tumour of Femur Cortex Causing Oncogenic Osteomalacia—Diagnostic Challenges and Clinical Out-comes. Endokrynologia Polska, 69, 205-210.
|
|
[7]
|
单凤玲, 孙贞魁, 沈晨天, 等. 磷酸盐尿性间叶肿瘤的临床特点及其综合影像学表现[J]. 国际放射医学核医学杂志, 2021, 45(8): 479-485.
|
|
[8]
|
Breer, S., Brunkhorst, T., Beil, F.T., et al. (2014) 68Ga DOTA-TATE PET/CT Allows Tumor Localization in Patients with Tumor-Induced Osteomalacia But Negative 111In-Octreotide SPECT/CT. Bone, 64, 222-227. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Weidner, N. (1991) Review and Update: Oncogenic Osteomala-cia-Rickets. Ultrastructural Pathology, 15, 317-333. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
张欣, 钟定荣, 邢荣格. 磷酸盐尿性间叶肿瘤12例临床病理分析[J]. 临床与实验病理学杂志, 2015, 31(4): 426-430.
|
|
[11]
|
Yamada, Y., Kinoshita, I., Kenichi, K., et al. (2018) Histopathological and Genetic Review of Phosphaturic Mesenchymal Tumours, Mixed Connective Tissue Variant. His-topathology, 72, 460-471. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Tajima, S. and Fukayama, M. (2015) CD56 May Be a More Useful Immunohistochemical Marker than Somatostatin Receptor 2A for the Diagnosis of Phosphaturic Mesenchymal Tumors. International Journal of Clinical and Experimental Pathology, 8, 8159-8164.
|
|
[13]
|
宋春红, 吴亮, 殷薇薇, 等. 3例不同部位磷酸盐尿性间叶性肿瘤临床病理特征分析[J]. 温州医科大学学报, 2022(2): 153-157.
|
|
[14]
|
Agaimy, A., Michal, M., Chiosea, S., et al. (2017) Phosphaturic Mesenchymal Tumors: Clinicopathologic, Immunohistochemical and Molecular Analysis of 22 Cases Expanding their Morphologic and Immunophenotypic Spec-trum. The American Journal of Surgical Pathology, 41, 1371-1380. [Google Scholar] [CrossRef]
|